| Primary information |
|---|
| ID | 13589 |
| Uniprot ID | P0DP55 |
| Description | Pro-neuropeptide Y [Cleaved into- Neuropeptide Y (NPY); C-flanking peptide of NPY] |
| Organism | Meiacanthus atrodorsalis |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Actinopterygii; Actinopteri; Neopterygii; Teleostei; Osteoglossocephalai; Clupeocephala; Euteleosteomorpha; Neoteleostei; Eurypterygia; Ctenosquamata; Acanthomorphata; Euacanthomorphacea; Percomorphaceae; Ovalentaria; Blenniimorphae; Blenniiformes; Blennioidei; Blenniidae (combtooth blennies); Blenniinae; Meiacanthus; Meiacanthus atro |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the NPY family. |
| Tissue Specificity | Expressed by the venom gland. Heavily expressed in the venom gland transcriptome. |
| Post Translational Modification | NA |
| Function | Neuropeptides Y are crucial for the regulation of cardiovascular processes such as blood pressure. Venom of Meiacanthus fangblennies shows a potent hypotensive bioactivity (tested on M.grammistes); but has no effect on the heart rate. Therefore; finding a neuropeptide Y sequence in M.atrodorsalis venom suggests that this protein act as a hypotensive agent (Probable). |
| Length | 99 |
| Molecular Weight | 11 |
| Name | NA |
| Sequence | NA |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|